Trial intelligence / Profile preview

Topical Timolol Combined With Cryotherapy for EGFR Inhibitor-induced Paronychia

NCT05165082Completed

Sponsor
Taipei Medical University WanFang Hospital
Start
Dec 2021
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in paronychia comparing Timolol + Cryotherapy with Placebo + Cryotherapy (2 arms). Primary endpoint: Scoring system for paronychia related to oncologic treatments at 8 weeks. Started Dec 2021; status: completed.

02

Drugs

timolol
03

Conditions

paronychia

Beyond the preview

Go deeper on NCT05165082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05165082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call